Which diseases can synthetic vaccines target?

They are used for cancers (e.g., breast, prostate) and infectious diseases (e.g., influenza, FMDV).

How are synthetic peptide vaccines designed?

They are designed using computational epitope prediction, chemical synthesis, and structure-based optimization for optimal immunogenicity.

Do synthetic vaccines require adjuvants?

Some are self-adjuvanting, while others use synthetic or nanoparticle-based adjuvants to boost immune responses.

What technologies are used in synthetic vaccine production?

Solid-phase peptide synthesis (SPPS), glycan conjugation, and nanocarrier systems (e.g., VLPs, LNPs) are common.

What distinguishes totally synthetic vaccines from traditional ones?

They use chemically synthesized components (peptides, adjuvants) instead of pathogen-derived materials, ensuring defined composition and reduced contamination risks.

Do you offer custom synthetic vaccine design for unique targets?

Yes, we provide tailored solutions, including antigen selection, adjuvant pairing, and preclinical validation for client-specific needs.

Totally Synthetic Vaccines Solution

Creative Biolabs offers comprehensive preclinical services for totally synthetic vaccine development, leveraging cutting-edge design and advanced technologies. Our expertise includes epitope prediction, antigen synthesis, carrier protein conjugation, and adjuvant optimization. We provide robust immunogenicity evaluation, safety assessment, and animal model testing to ensure optimal vaccine efficacy. With customizable solutions and a proven track record, we support your synthetic vaccine projects from concept to preclinical validation, accelerating the path to clinical trials. Partner with us for innovative, high-precision vaccine design tailored to your specific needs.

Talk To Our Vaccine Experts View Services Available products

End-to-end totally synthetic vaccine solutions

What is a Totally Synthetic Vaccine?

A totally synthetic vaccine is a type of vaccine composed entirely of chemically synthesized components, such as peptides or carbohydrates, rather than being derived from live or inactivated pathogens. These vaccines are designed to mimic specific antigens found on pathogens or abnormal cells, enabling the immune system to recognize and respond to them. Because they are synthetically produced, these vaccines offer high precision, stability, and safety, with no risk of infection. They are especially useful in targeting viruses that are difficult to culture or mutate rapidly, such as influenza. Synthetic vaccines can also be engineered to include multiple antigens or adjuvants to enhance immune responses.

Comprehensive Totally Synthetic Vaccine Preclinical Solution

At Creative Biolabs, our Totally Synthetic Vaccine service is a cut above the rest. We blend state - of - the - art synthetic techniques with in - depth immunological insights. Our services cover custom - designed synthetic antigens, precise carrier molecule integration, and advanced adjuvant strategies. By combining these elements, we create vaccines with enhanced immunogenicity and safety profiles, all tailored to your specific needs.

Comprehensive Service Portfolio

Vaccine Design Adjuvant selection Analysis & ValidationFormulation Development Preclinical Testing

Customized Totally Synthetic Vaccine Design

Pathogen-Specific Design: Creative Biolabs leverages advanced computational modeling, structure-based antigen design, and AI-driven epitope prediction to develop highly specific and safe synthetic vaccines.
Platform Capabilities: Our platform supports de novo peptide synthesis, glycan engineering, and multi-epitope fusion to enhance immunogenicity and vaccine performance.

Adjuvant Development & Optimization

Adjuvant Screening & Evaluation: High-throughput in vitro and in vivo assays to identify potent synthetic adjuvants that enhance immune responses.
Rational Adjuvant Design: Structure-guided modification and nano-formulation of synthetic adjuvants for improved stability and targeted delivery.
Synergistic Formulation: Co-encapsulation of adjuvants with synthetic antigens in nanoparticles to maximize immunogenicity while minimizing systemic toxicity.

Analytical Development & Preclinical Validation

Analytical Characterization: Comprehensive antigen quantification, purity assessment (HPLC, SDS-PAGE), and structural verification (MS, CD spectroscopy).
Stability & Potency Testing: Real-time/accelerated stability studies and in vitro potency assays (e.g., binding affinity, neutralizing antibody evaluation).
Safety & Toxicology: In vitro/in vivo toxicity screening (pyrogenicity, sterility) and biodistribution studies.
Immunogenicity Profiling: Humoral/cellular immune response evaluation (ELISpot, flow cytometry) in preclinical models.

Formulation & Process Development

Antigen Stabilization & Adjuvant Screening: Optimize vaccine stability with advanced lyophilization techniques and screen adjuvants (e.g., TLR agonists, nanoparticles) for enhanced immunogenicity.
Formulation Optimization: Develop scalable, GMP-compatible formulations (e.g., liposomes, VLPs) to ensure antigen integrity and delivery efficiency.
Analytical Method Development: Establish assays for potency (e.g., SPR, ELISA), sterility, and endotoxin testing to meet regulatory standards.

Preclinical Testing

Efficacy Testing: Challenge studies in relevant animal models (e.g., murine, non-human primates) to validate vaccine protection against target pathogens.

Featured Totally Synthetic Vaccine Design Services

Synthetic Vaccine Particle Design

Fully synthetic components (peptides, carbohydrates, adjuvants) for precise immune targeting
Highly customizable structure for tailored antigenicity/immunogenicity
Scalable chemical synthesis ensuring consistent quality
Enhanced safety profile with defined composition

How Dose Totally Synthetic Vaccine Solution Work?

1. Antigen Design and Optimization

Pathogen genome analysis based on high-throughput sequencing platform
AI online platform predicts highly immunogenic epitopes
Optimizing and modifying candidate antigens to enhance their immunogenicity and stability.

2. Immunization Strategy Development

Outer Membrane Vesicle Platform induces antigen expression
Optimization of adjuvant compatibility (aluminum adjuvant, TLR agonist)
Delivery system customization (nanoparticles/liposomes)

3. Immunogenicity Assessment

Humoral immunity testing (IgG/IgA subtypes, neutralizing antibody titers)
Cellular immune assay (Th1/Th2/Th17 response profile)
ADCP/ADCD functional verification

4. Animal Model Verification

Customized challenge model (mouse/guinea pig/rabbit)
Protection effectiveness evaluation (LD50, Totally Synthetic load monitoring)
Safety assessment (local/systemic toxicity)

5. Report

Screening analysis reports
Test data reports
Project design document

Online Inquiry

Getting Started with Your Vaccine Project

Professional Vaccine Solution platform

Antigen Prediction System Platform

Our Antigen Prediction System Platform integrates advanced bioinformatics and computational biology tools to identify and prioritize immunogenic antigens. Leveraging cutting-edge algorithms, we analyze pathogen genomes or cancer markers to predict key epitopes that elicit robust immune responses. This platform enables the rational design of vaccines by pinpointing high-potency antigens, significantly accelerating the development process for bacterial, viral, fungal, parasitic, and cancer-targeted vaccines. By combining traditional immunology with state-of-the-art predictive modeling, we ensure optimal antigen selection for maximum immunogenicity and efficacy.

Protein Expression Platform

The Protein Expression Platform at Creative Biolabs offers versatile solutions for producing recombinant antigens using multiple expression systems. We specialize in optimizing bacterial (e.g., E. coli), yeast, insect, and mammalian cell systems to meet diverse production needs. Our expertise in genetic engineering allows us to tailor expression vectors, culture conditions, and purification protocols for high-yield, biologically active proteins. Whether for preclinical research or large-scale manufacturing, our platform ensures consistent production of immunogenic proteins, supporting the development of vaccines with enhanced stability and immunogenicity. We seamlessly integrate expression technologies with downstream analytical and formulation services to streamline the vaccine development pipeline.

Modular Delivery System Platform

Our Modular Delivery System Platform is designed to enhance vaccine potency and delivery efficiency through customizable, multi-component formulations. Focused on optimizing delivery mechanisms, we develop lipid-based nanoparticles, viral-like particles (VLPs), and other nano-carriers to protect antigens, improve cellular uptake, and modulate immune responses. The modular design allows for precise integration of adjuvants, targeting ligands, and protective matrices, enabling tailor-made systems for various vaccine types—from prophylactic to therapeutic.

Why Choose Our Totally Synthetic Vaccine Services?

Precision Design

We custom-engineer vaccines from synthetic antigens, ensuring precise targeting of immunogenic sites for enhanced specificity and reduced off-target effects, leading to safer candidates.

Enhanced Safety Profile

Our synthetic approach eliminates live pathogens and animal-derived components, significantly minimizing reactogenicity and improving the overall safety profile of vaccine candidates.

Optimized Immunogenicity

Through rational design of synthetic vaccine particles and strategic adjuvant co-delivery, we optimize immune responses, ensuring robust and long-lasting protection against various diseases.

Streamlined Scalability

Leveraging chemical synthesis, our processes enable highly reproducible and scalable production, facilitating rapid and cost-effective manufacturing for both research and future clinical needs.

Available Products

Antigen Products Antibody Products Adjuvant Products Delivery System related Products

Array Kits Cell Culture Medium Proudcts

FAQs About Our Totally Synthetic Vaccine Solution

Which diseases can synthetic vaccines target?

They are used for cancers (e.g., breast, prostate) and infectious diseases (e.g., influenza, FMDV).
How are synthetic peptide vaccines designed?

They are designed using computational epitope prediction, chemical synthesis, and structure-based optimization for optimal immunogenicity.
Do synthetic vaccines require adjuvants?

Some are self-adjuvanting, while others use synthetic or nanoparticle-based adjuvants to boost immune responses.
What technologies are used in synthetic vaccine production?

Solid-phase peptide synthesis (SPPS), glycan conjugation, and nanocarrier systems (e.g., VLPs, LNPs) are common.
What distinguishes totally synthetic vaccines from traditional ones?

They use chemically synthesized components (peptides, adjuvants) instead of pathogen-derived materials, ensuring defined composition and reduced contamination risks.
Do you offer custom synthetic vaccine design for unique targets?

Yes, we provide tailored solutions, including antigen selection, adjuvant pairing, and preclinical validation for client-specific needs.

Related Resources

Download Resources

Literature Center

Podcast